Isotopen Technologien Munchen Competitors and Similar CompaniesClear all

Isotopen Technologien Munchen's competitors and similar companies include BioInvent, Inventiva, Pharma Mar and Therapeia.
Isotopen Technologien Munchen
Isotopen Technologien Munchen
ITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment.
BioInvent
BioInvent
BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
Inventiva
Inventiva
Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases.
Pharma Mar
Pharma Mar
Pharma Mar is a biopharmaceutical company that engages in the discovery and development of marine-derived anticancer drugs.
Therapeia
Therapeia
Therapeia is a company that specializes in the development of diagnostic and therapeutic radiopharmaceuticals for unmet patient needs.
Founding Date
Founding Date
2004
Founding Date
1997
Founding Date
2011
Founding Date
1986
Founding Date
2007
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Garching bei München, DE HQ
München, DE
Locations
Lund, SE HQ
Locations
Daix, FR HQ
Locations
Colmenar Viejo, ES HQ
Madrid, ES
Locations
Dresden, DE HQ
Employees
Employees
5403% increase
Employees
118
Employees
114
Employees
500
Employees
N/A
Valuation ($)
Valuation ($)
N/A
Valuation ($)
285.9 m
Valuation ($)
231 m
Valuation ($)
1.4 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
kr226.5m (FY, 2025)
Revenue (est.)
€4.5m (FY, 2025)
Revenue (est.)
€221.4m (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
€12.3m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
kr226.6m (FY, 2025)
Gross profit
€7.9m (FY, 2025)
Gross profit
€232m (FY, 2025)
Gross profit
N/A
Net income
Net income
N/A
Net income
(kr332.9m) (FY, 2025)
Net income
(€354.1m) (FY, 2025)
Net income
€75m (FY, 2025)
Net income
N/A
For sources of this data, please see the company profile

View Company Profiles

BioInvent
HQ
Lund, SE
Employees
118

BioInvent focuses on the discovery and development of antibody-based drugs against cancer.

View company
Inventiva
HQ
Daix, FR
Employees
114

Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases.

View company
Pharma Mar
HQ
Colmenar Viejo, ES
Employees
500

Pharma Mar is a biopharmaceutical company that engages in the discovery and development of marine-derived anticancer drugs.

View company
Therapeia
HQ
Dresden, DE

Therapeia is a company that specializes in the development of diagnostic and therapeutic radiopharmaceuticals for unmet patient needs.

View company